perfluoropentane has been researched along with Nasopharyngeal Carcinoma in 1 studies
*Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Feng, G; Jing, X; Lin, L; Sun, D; Yang, D; Zhang, M | 1 |
1 other study(ies) available for perfluoropentane and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
Topics: Acoustics; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Emulsions; Folic Acid; Humans; Nanoparticles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Tissue Distribution | 2022 |